The Next Realm of Patient Care Is Bringing Pharma & MedTech Together

The COVID-19 pandemic underscored the appeal of in-home patient care, offering a convenient and safe alternative for both patients and physicians. However, to enhance the accuracy and reliability of these emerging healthcare delivery models, collaboration between medical device companies and pharmaceutical entities is imperative. The development of clinical-grade devices capable of providing precise patient data is essential for optimizing treatment outcomes. In an upcoming session at BIOME Device Boston, titled "Clinical-grade Medical Devices for New Healthcare Delivery Models and Partnering with Pharma," a panel of experts will delve into the latest trends in evolving healthcare models. They will explore strategies for medical device companies to establish partnerships with pharmaceutical counterparts, fostering the creation of innovative devices tailored to the unique requirements of this burgeoning sector. Such collaborations hold the promise of improving patient care and advancing the capabilities of healthcare delivery in the post-COVID era.